Email this article THE FIRST EXPERIENCE WITH INGARON TREATMENT FOR CONJUNCTIVAL MELANOMA
- Authors: Brovkina A.F.1, Grishina Y.Y.1, Yatsenko O.Y.1, Andreichenko A.M.1
-
Affiliations:
- Russian Medical Academy of Postgraduate Education, Moscow
- Issue: Vol 2, No 2 (2012)
- Pages: 9-12
- Section: OPHTHALMOONCOLOGY
- Published: 15.04.2012
- URL: https://ogsh.abvpress.ru/jour/article/view/54
- DOI: https://doi.org/10.17650/2222-1468-2012-0-2-9-12
- ID: 54
Cite item
Abstract
The paper describes the first experience with the Russian drug Ingaron from an interferon-group in the treatment of patients with conjunctival melanoma. The positive result obtained during 5-to-62-month follow-ups allows its therapeutic action to be positively appreciated.
Keywords
About the authors
A. F. Brovkina
Russian Medical Academy of Postgraduate Education, Moscow
Author for correspondence.
Email: anab@list.ru
Russian Federation
Ye. Ye. Grishina
Russian Medical Academy of Postgraduate Education, MoscowRussian Federation
O. Yu. Yatsenko
Russian Medical Academy of Postgraduate Education, MoscowRussian Federation
A. M. Andreichenko
Russian Medical Academy of Postgraduate Education, MoscowRussian Federation
References
Supplementary files
